Ancora Advisors’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-526,000
| Closed | -$329K | – | 1995 |
|
|
2023
Q1 | $329K | Hold |
526,000
| – | – | 0.01% | 542 |
|
|
2022
Q4 | $413K | Buy |
526,000
+29,000
| +6% | +$22.8K | 0.01% | 513 |
|
|
2022
Q3 | $355K | Hold |
497,000
| – | – | 0.01% | 562 |
|
|
2022
Q2 | $313K | Buy |
497,000
+120,850
| +32% | +$76.1K | 0.01% | 611 |
|
|
2022
Q1 | $262K | Hold |
376,150
| – | – | 0.01% | 708 |
|
|
2021
Q4 | $263K | Buy |
376,150
+375,150
| +37,515% | +$262K | 0.01% | 715 |
|
|
2021
Q3 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 2170 |
|
|
2021
Q2 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1901 |
|
|
2021
Q1 | $1K | Buy |
+1,000
| New | +$1K | ﹤0.01% | 1680 |
|